Pulmonary sarcoidosis in a patient with multiple sclerosis on daclizumab therapy
No Thumbnail Available
Authors
Rhone, Elijah Edward
Cho, Peter Siu Pan
Birring, Surinder S.
Galloway, James
Silber, Eli
Check for full-text access
Issue Date
2018
Type
Article
Language
Keywords
Alternative Title
Abstract
As new immunomodulatory therapies continue to be licensed for use in Multiple Sclerosis, it is important to remain vigilant for new, unexpected associations relating to these medications. We highlight this by reporting on a case of a 45-year-old man who developed systemic, non-specific symptoms following long term use of daclizumab and was subsequently diagnosed with sarcoidosis. We go on to briefly discuss the action of daclizumab, in particular the effect it has on CD56
Description
Citation
Publisher
License
Journal
Multiple Sclerosis and Related Disorders
Volume
20